This inventor holds 1 USPTO granted patent. Top assignee: C4 Therapeutlcs, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Ryan E Michael
Introduction
Ryan E Michael is an accomplished inventor based in Erie, Colorado. He has made significant strides in the field of biotechnology, particularly in the development of compounds that target specific proteins involved in cancer progression. His work is crucial in the ongoing fight against various forms of cancer.
Latest Patents
Ryan holds a patent for "Compounds for targeted degradation of RET." This patent describes compounds of Formula (I) that act as protein degradation inducing moieties for the proto-oncogene tyrosine-protein kinase receptor (RET). These compounds can be utilized to treat disorders mediated by the RET protein, including cancers and tumors. His innovative approach offers new avenues for therapeutic interventions in oncology.
Career Highlights
Ryan is currently employed at C4 Therapeutics, Inc., where he continues to advance his research and development efforts. His work at this company allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in targeted therapies.
Collaborations
Ryan has worked alongside notable colleagues such as James A Henderson and Christopher G Nasveschuk. Their combined expertise fosters a collaborative environment that enhances the potential for innovative solutions in cancer treatment.
Conclusion
Ryan E Michael's contributions to the field of biotechnology, particularly through his patent on targeted degradation of RET, highlight his commitment to advancing cancer treatment. His work at C4 Therapeutics, Inc. and collaborations with esteemed colleagues further underscore his impact in this vital area of research.